VSee Health, Inc. Gain (Loss) on Extinguishment of Debt
VSee Health, Inc. (VSEE) reported Gain (Loss) on Extinguishment of Debt of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-14
- VSee Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$367.81K.
- VSee Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was $367.81K.
- VSee Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $126.17K.
- VSee Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- VSee Health, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was -$645.98K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt as first filed | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$367.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $126.17K derived: sum of 3 quarters · filed 2026-08-14 | $126.17K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $367.81K 10-Q · filed 2026-05-15 | $493.98K derived: sum of 2 quarters · filed 2026-08-14 | $493.98K derived: sum of 3 quarters · filed 2026-08-14 | $367.85K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-01-15 | $181.50K 10-Q · filed 2026-08-14 | ||||||||
| 2025-12-31 | $126.17K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-14 | $126.17K derived: sum of 2 quarters · filed 2026-08-14 | $42.00 derived: sum of 3 quarters · filed 2026-08-14 | $42.00 10-Q · filed 2026-08-14 | -$221.20K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | -$126.13K derived: sum of 2 quarters · filed 2025-11-20 | -$126.13K 10-Q · filed 2025-11-14 | -$126.13K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2025-06-30 | -$126.13K 10-Q/A · filed 2025-11-20 | -$126.13K 10-Q · filed 2026-08-14 | -$126.13K derived: sum of 3 quarters · filed 2026-05-15 | -$772.10K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | -$645.98K derived: sum of 3 quarters · filed 2026-05-15 | -$645.98K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$645.98K derived: sum of 2 quarters · filed 2026-03-31 | -$645.98K derived: sum of 3 quarters · filed 2026-03-31 | -$645.98K 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$645.98K 10-Q · filed 2025-11-14 | -$740.98K 10-Q · filed 2024-11-14 | -$645.98K derived: sum of 2 quarters · filed 2025-11-20 | -$645.98K 10-Q · filed 2025-11-14 | -$740.98K 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $0.00 10-Q/A · filed 2025-11-20 | $0.00 10-Q/A · filed 2025-11-20 | |||||||
| 2023-11-21 | $42.00 10-Q · filed 2026-05-15 | $42.39K 10-K · filed 2026-03-31 | |||||||
| 2021-11-29 | $79.16K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |